Core Viewpoint - The CXO industry is transitioning from a cyclical model driven by overall demand recovery to a structural differentiation model where company-specific platform capabilities are the key drivers of performance [3][6][31]. Group 1: Platform Depth - Platform depth is defined by the ability to cover intermediates, APIs, and formulations, allowing for multi-technology platform synergy [5]. - The extension into formulation services is seen as a strategic move that significantly increases the value share of individual molecules, with potential order space rising from 5%-8% to over 10% when including formulation [8]. - Companies like WuXi AppTec have shown rapid growth in formulation capacity, indicating real demand in the market [9]. - Entering the formulation business has higher barriers due to stringent quality and compliance requirements, which amplifies the differences in platform capabilities among companies [11][12]. - The choice of technological pathways, such as solid-phase synthesis for small nucleic acids, is crucial for future participation in new therapies and is a key competitive dimension [12]. Group 2: Capacity Speed - Capacity speed determines how quickly potential value can be converted into market share during demand fluctuations [14]. - Leading companies have demonstrated significant capacity expansion, with WuXi AppTec's TIDES business scaling from less than 10,000 liters to over 100,000 liters in just three years [14][18]. - Operational efficiency improvements, such as enhanced equipment utilization through digital tools, can effectively increase capacity without additional capital investment [19]. - The current industry landscape shows a lack of uniform capacity expansion, with head companies focusing on structural investments rather than pure scale expansion [29]. Group 3: Customer Binding - The decision-making process for pharmaceutical companies is shifting from price competition to prioritizing platform security and long-term collaboration [22]. - Companies that can provide higher technical complexity and maintain stable delivery capabilities are more likely to become core partners rather than backup suppliers [22][26]. - The binding relationship is reinforced by strategic investments in promising clinical projects, which can lead to deeper involvement as projects progress [25]. - The structure of the industry is enhancing binding relationships, particularly in concentrated supply chains like small nucleic acids, where key raw materials are difficult to replace [26]. Group 4: Industry Differentiation - The CXO industry is moving from a unified cyclical phase to a structural cycle dominated by capability differences, leading to a widening operational gap between leading and lagging companies [27][29]. - The demand for high-quality capacity is increasing, particularly as mature projects enter the commercialization phase, while new technology routes are favoring suppliers with strong platform capabilities [29]. - The evolution of the competitive landscape is more aligned with platform-based industries rather than traditional manufacturing, emphasizing the importance of technology systems, delivery capabilities, and customer structures [29]. Group 5: Conclusion - The CXO industry is undergoing a fundamental logic restructuring, shifting focus from demand fluctuations to platform capabilities, which will redefine valuation systems [31]. - The three core variables—platform depth, capacity speed, and customer binding—are interrelated and crucial for long-term growth and stability [31]. - Identifying companies with platform characteristics that can extend into high-value segments, demonstrate leading capacity expansion, and form long-term partnerships will be key to achieving stable excess returns in the industry [31].

Core Viewpoint - Pop Mart announced that by 2025, global sales of all IP and product categories will exceed 400 million units, with THE MONSTERS category alone exceeding 100 million units [1]. Group 1: 2025 Growth Analysis - The company experienced a typical "single super IP + category breakthrough" growth, with revenue expanding nearly threefold year-on-year, driven primarily by Labubu's global popularity and significant monetization efficiency from plush toys [1][3]. - HSBC's analysis indicates that revenue from The Monsters (Labubu) is expected to grow approximately 582% year-on-year, contributing an estimated 47% to total revenue, while plush toy revenue is projected to grow about 720%, contributing 60% [3][10]. - Excluding the contributions from The Monsters and plush toys, the company still anticipates a revenue growth of approximately 106% and 51% respectively, indicating that the existing business is not stagnant [10]. Group 2: 2026 Projections - HSBC predicts that the "rush-to-buy" effect will fade, normalizing the ARPU of repeat members, which will shift growth back to a standard retail expansion model. Consequently, revenue growth forecasts for 2026 have been adjusted down from 30.6% to 23.7% [4][11]. - The company expects PRC revenue growth of about 13.0% and overseas growth of approximately 35.7% in 2026, with the latter serving as a buffer against domestic ARPU declines [12]. Group 3: Valuation and Future IP Development - HSBC believes that the market has already begun to price in the "Labubu lifecycle risk" through valuation compression, with a significant drop in forward PE ratios despite a 394% increase in one-year forward EPS since early 2025 [13]. - UBS highlights the strong initial performance of the new IP Twinkle, with significant sales figures during key promotional periods, indicating potential for future growth [13][14]. - Both HSBC and UBS view upcoming data as critical validation points for assessing performance in both domestic and international markets, particularly in the U.S. [14].

Core Viewpoint - Pop Mart aims to achieve global sales of over 400 million units across all IP and product categories by 2025, with the "THE MONSTERS" category expected to exceed 100 million units [1] Group 1: 2025 Growth Drivers - The company is experiencing a typical "single super IP + category breakthrough" growth model, with revenue expected to expand nearly threefold year-on-year, driven primarily by the global popularity of Labubu and significant monetization efficiency from plush toys [1] - HSBC's analyst Lina Yan predicts that while the hyper-growth from Labubu will fade, the platform's capabilities will persist, marking 2026 as a year for "re-establishing the baseline" [1] - UBS believes that the data alleviates market concerns regarding reliance on a single hit product, with new IP Twinkle showing strong initial performance in early 2026, providing a window for continued growth [1] Group 2: Revenue and Profit Forecast Adjustments - HSBC has lowered its revenue and profit growth forecasts for 2026, citing a decline in member repurchase intensity and growth rate, while emphasizing that valuations have already accounted for IP lifecycle risks [2] - The company’s revenue growth in 2025 is expected to be significantly driven by repeat member purchases, with ARPU from repeat members contributing nearly half of the revenue growth in mainland China [3] Group 3: 2026 Growth Framework - HSBC anticipates that the normalization of ARPU for repeat members will shift growth from explosive to a more standard retail expansion trajectory, leading to a reduction in revenue growth forecast from 30.6% to 23.7% for 2026 [4] - The expected revenue growth for 2026 in mainland China is approximately 13.0%, while overseas growth is projected at around 35.7%, with a focus on expanding retail POS locations [4] Group 4: Execution Risks and Market Dynamics - The risks identified are primarily execution-related, including supply chain issues, price inflation from scalpers, and competition, which could impact the brand and sales [5] - HSBC notes that the market has already begun to price in the lifecycle risks associated with Labubu, with a significant drop in forward PE ratios despite a rise in forward EPS [6] Group 5: New IP and Market Validation - The success of new IPs like Twinkle and their interaction with overseas markets will be critical for sustaining growth post-Labubu, with initial sales figures indicating strong performance [6][7] - Both HSBC and UBS view upcoming quarterly sales data as crucial for validating market performance, particularly in the U.S., and emphasize the importance of sustainable membership management and product expansion [7]

Core Viewpoint - The success of Pop Mart is attributed to its platform capabilities rather than a single IP, with emerging IPs like Twinkle Twinkle and Crybaby expected to significantly contribute to revenue in the coming years [1][3][4]. Summary by Sections Platform Value - Morgan Stanley emphasizes that the market underestimates Pop Mart's platform value and its IP incubation capabilities, which are seen as the core long-term investment value [3][6]. - The focus on a single IP's ceiling has led investors to overlook the company's broader platform capabilities [3][6]. Emerging IP Growth Potential - Twinkle Twinkle has shown strong market demand, with products selling out quickly at the Beijing Toy Expo, indicating its potential as a major revenue contributor from 2025 onwards [4]. - Crybaby's lifestyle product line, with an average price exceeding 250 RMB, demonstrates significant sales growth potential, despite supply constraints on plush toys [4]. Globalization and IP Diversification - Pop Mart is expanding its IP diversity through global operations, with existing IPs primarily from Greater China, while also tapping into artists from Thailand and the U.S. [5]. - The company aims to leverage local markets to incubate local artists and their creations as international market scales grow [5]. Core Investment Value - The intrinsic value of Pop Mart lies in its platform capabilities, which enable the success of its IPs, a factor that is often overlooked by the market [6]. - The report suggests a reasonable valuation based on a projected 46 times price-to-earnings ratio for 2025, indicating a PEG ratio of approximately 1.4 for a high-growth consumer company with global expansion potential [6].

Core Insights - Morgan Stanley analysts emphasize that Pop Mart's platform value is underestimated by the market, focusing too much on individual IP ceilings rather than the company's core long-term investment value in platform incubation [1][4]. Group 1: IP Growth Potential - The Twinkle Twinkle IP showcased strong market demand at the Beijing Toy Expo, with products selling out quickly, indicating its potential as a significant revenue contributor from 2025 onwards [2]. - Crybaby's lifestyle product line, with an average price exceeding 250 RMB, demonstrates substantial sales growth potential, although plush toy demand is currently limited by supply constraints [2]. Group 2: Global Expansion and IP Diversification - Pop Mart has four regional sales segments, primarily sourcing its IP from Greater China, with exceptions like Crybaby from Thailand and Peach Riot from the U.S. The company has significant potential to tap into artist resources in the U.S., Europe, Japan, and Southeast Asia [3]. - The report notes that each new IP requires a sufficiently large local market to generate initial momentum, making the focus on Greater China a natural choice for early IP development [3]. Group 3: Platform Capability as Core Investment Value - Analysts argue that the true investment value lies in Pop Mart's platform capabilities rather than just the success of individual IPs, which is often misjudged by investors [4]. - Data shows that Labubu accounted for only 6% of group sales two years ago, while now it is globally recognized, with Crybaby and Twinkle Twinkle also gaining strong market attention [4]. - The implied PEG ratio of approximately 1.4 for the years 2025-2027 is considered reasonable for a high-growth consumer company with global expansion potential [4].